Lady Gaga Tickets @ Sprint Center in Kansas City, MO: Ticket Down Slashes Lady Gaga Concert Ticket Prices in Kansas City, Missouri at Sprint Center for 2017 “Joanne Tour” & Extends Promo/Coupon/Offer

Ticket Down is a reputable source of Lady Gaga tickets at Sprint Center in Kansas City – add promo code LADYGAGA2017
Ticket Down has cheap Lady Gaga tickets at Sprint Center in Kansas City on Wednesday, November 15th. This well known and trusted secondary ticket site is offering customer appreciation promo code LADYGAGA2017 for added savings.

Ticket Down is a reputable source of Lady Gaga tickets at Sprint Center in Kansas City on Wednesday, November 15th. Sprint Center will also host the following events in 2017: Brantley Gilbert, Charlie Wilson, Ariana Grande, Radiohead, Chris Tomlin, John Mayer, Lionel Richie & Mariah Carey, The Chainsmokers, Red Hot Chili Peppers (RHCP), Roger Waters, Tom Petty and the Heartbreakers, Future, New Kids on the Block (NKOTB), Def Leppard, OneRepublic, Queen & Adam Lambert, Iron Maiden, Luke Bryan, Bruno Mars, Green Day, Coldplay, Tim McGraw & Faith Hill and 2Cellos.

As the worldwide tour for Lady Gaga’s latest album, Joanne, kicks off, it’s hard to keep excitement in check. After incredible performances at the Grammys and the Super Bowl, fans are keeping the buzz going while they wait for the show later this year.

By now, everyone who is interested knows that Joanne was created in celebration of Gaga’s late aunt, a woman with whom Gaga shares a name and a passion for creativity. Joanne Stefani (as opposed to Gaga’s name, Stefani Joanne) was a poet before passing away at the age of 19. Though Gaga was born just over a decade later, she always felt a connection to the aunt she never met.

But the album is about far more than Gaga’s connection to the past. In the stripped-down sounds of Joanne, Gaga explores themes like family and relationships that cross all points of time. In addition to songs that explore the lessons she learned from Aunt Joanne’s life, Gaga also records songs about past relationships with men, in particular the “wild men” who broke her heart along the way.

Originally, Joanne was meant to be released right after 2013’s Artpop, a decision that clearly didn’t come to fruition. After spending three more years on the album, Gaga released Joanne to critical acclaim across the board. With influences from country music, blues, and even a bit of Bollywood, it was nothing like her fans had ever heard from her before – and considering the very personal well from which Gaga drew inspiration for this album, perhaps that is the most telling thing about Joanne.

Heading back to the studio with country singer-songwriter Dallas Davidson, Gaga has made it clear that she’s not done exploring this new soulful sound, giving fans hope that they’ll see even more of the singer’s personal stories in future albums.

The Sprint Center is located in the downtown section of Kansas City. It opened in 2007 and saw Elton John be the first artist to perform at the venue. It is the current home of the Big 12 Men’s Basketball Tournament and is used mostly for various types of entertainment events. Some of the notable artist that have performed on the stage at the Sprint Center include Garth Brooks, Foo Fighters, Jason Aldean, AC/DC, Taylor Swift and Demi Lovato.

About TicketDown.com:

Ticket Down delivers tickets to sold out concerts and events worldwide when no one else can, and they do so at discounted prices. This popular ticket exchange also has Lady Gaga tickets at Sprint Center in Kansas City for all budgets and seating preferences. Find Lady Gaga floor seats, front row seats, VIP seating, general admission (GA), parking passes and more. Add promo/coupon code LADYGAGA2017 for added savings on any ticket order.

Note: Ticket Down is not associated with any of the artists or venues mentioned in this release. The names that are used in this release are purely for descriptive purposes. We are not affiliated with or do we endorse any artists or venues in this release. Ticket Down and JP Media, LLC are

Media Contact
Company Name: JP Media
Contact Person: Ticket Down
Email: Send Email
Phone: 1-877-870-3653
Country: United States
Website: www.ticketdown.com

Total Cray Valley to Exhibit and Present New Technology for Improved PP Melt Strength at 2017 Polyolefin Conference

News Image

Total Cray Valley (TCV) will exhibit at this year’s SPE International Polyolefin Conference and present a paper titled “A New Method to Modify PP for Improved Melt Strength.”

TCV has developed technology to overcome the long-standing melt strength deficiency of polypropylene (PP). The paper will detail a way to modify conventional PP resins with zinc salts to achieve performance similar to high melt strength PP. TCV’s global business development manager Anthony Marozsan will present the paper on Feb. 28 at 11:30 a.m.

TCV will exhibit at booth 40, where attendees can learn how additives like Dymalink® coagents enhance plastic formulations with improved tensile strength, heat deflection temperature (HDT) and flexural modulus.

The International Polyolefin Conference takes place Feb. 22 to 25 at the Hilton Houston North in Houston, Texas. It is hosted by the Society of Plastics Engineers (SPE) South Texas Section. For more information and to register for the conference, go to http://www.spe-stx.org.

For more information on Total Cray Valley’s Dymalink coagents for improved polyolefin performance, go to http://www.crayvalley.com/products/dymalink-zinc-acrylate/specialty.

About Total Cray Valley
Globally based in Paris, Total Cray Valley is part of Total’s Polymers division within the Refining & Chemicals branch. Total Cray Valley manufactures Wingtack® and Cleartack® hydrocarbon resins, Poly bd®, Ricon® and Krasol® liquid polybutadiene resins, SMA® copolymer resins, and Dymalink® monomers. These products are used as raw materials and additives for adhesives, rubber, electronics, thermoplastics, coatings and other applications.

# # #

Contact: Chris Henneghan
Schubert b2b
610-269-2100, ext. 230
schenneghan(at)schubertb2b.com

Share article on social media or email:

Amedisys Announces Fourth Quarter Earnings Release and Conference Call Date

BATON ROUGE, La., Feb. 20, 2017 (GLOBE NEWSWIRE) — Amedisys, Inc. (NASDAQ:AMED), announced today that it will report results for the fourth quarter ended December 31, 2016 after the market closes on February 28, 2017.  The Company will host an investor conference call to discuss these results at 11:00 a.m. ET on March 1, 2017.
To participate on the conference call, please call a few minutes before 11:00 a.m. ET to either (877) 524-8416 (Toll-Free) or (412) 902-1028 (Toll).  A replay of the conference call will be available through April 1, 2017.  The replay dial-in number is (877) 660-6853 (Toll-Free) or (201) 612-7415 (Toll) and reference conference ID #13654607.A live webcast of the call will be accessible through our website on our Investor Relations section at the following web address: http://investors.amedisys.com.About Amedisys:
Amedisys, Inc. is a leading healthcare at home Company delivering personalized home health, hospice and personal care. Amedisys is focused on delivering the care that is best for our patients, whether that is home-based personal care; recovery and rehabilitation after an operation or injury; care focused on empowering them to manage a chronic disease; or hospice care at the end of life. More than 2,200 hospitals and 61,900 physicians nationwide have chosen Amedisys as a partner in post-acute care. Founded in 1982, headquartered in Baton Rouge, LA with an executive office in Nashville, TN, Amedisys is a publicly held company. With more than 16,000 employees, in 420 care centers in 34 states, Amedisys is dedicated to delivering the highest quality of care to the doorsteps of more than 360,000 patients in need every year. For more information about the Company, please visit: www.amedisys.com.
We use our company website as a channel of distribution for important company information. Important information, including press releases, analyst presentations and financial information regarding the Company is routinely posted on and accessible on the “Investor Relations” subpage of our website, which is accessible by clicking on the tab labeled “Investors” on our website home page. Visitors to our website can also register to receive automated e-mail and other notifications alerting them to when new information is made available on the Investor Relations subpage of our website. In addition, we make available on the Investor Relations subpage of our website (under the link “SEC filings”) free of charge our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, ownership reports on Forms 3, 4 and 5 and any amendments to those reports as soon as practicable after we electronically file such reports with the SEC. Further, copies of our Certificate of Incorporation and Bylaws, our Code of Ethical Business Conduct and the charters for the Audit, Compensation, Nominating and Corporate Governance, Quality of Care and Compliance and Ethics Committees of our Board are also available on the Investor Relations subpage of our website (under the link “Corporate Governance”).Contact:

Amedisys, Inc.
David Castille
Managing Director, Finance and Assistant Treasurer
225.299.3665
david.castille@amedisys.com

IDEX Launches Glass and Ceramic Fingerprint Sensors for Smartphones

IDEX, a leading developer of advanced fingerprint solutions for mass markets, today announced the expansion of its broad portfolio of fingerprint solutions with the launch of a new series of glass and ceramic touch sensors for mobile applications. IDEX’s new fingerprint sensor solutions are based on the company’s silicon-based Cardinal architecture with enhanced imaging performance to replace conventional coating by sensing through glass and ceramic covers. The new glass and ceramic sensor product range has been developed in partnership with CanvasBio.

“Our newest form factor sensors offer the sleek look and feel of glass to mobile OEMs, which are increasing relying on glass to strengthen the industrial designs of next generation smartphones. Intended for front mounted mobile applications, IDEX’s glass and ceramic sensor solutions combine an elegant cosmetic solution and strong biometric performance at a very competitive price point.

We are confident this expansion of our touch fingerprint sensor portfolio will continue the commercial momentum we have built in the mobile market,” said Dr Hemant Mardia, CEO of IDEX ASA.

IDEX will demonstrate its new glass and ceramic fingerprint sensor at the IDEX meeting room in Hall 2 to selected customers during Mobile World Congress in Barcelona from February 27 March 2.

About IDEX

IDEX (idex.no) develops and sells advanced fingerprint sensor technology and products. The company’s technology is used in a range of biometrically enabled applications within three core markets: Mobile, Smart Cards and Internet of Things (IoT). IDEX’s addressable market represents a fast-growing multi-billion unit opportunity.

IDEX’s technology includes both the conventional silicon sensor and a unique off-chip technology, which means that the company can offer its partners solutions which are flexible and cost efficient.

IDEX ASA is a Norwegian company, founded in 1996 and listed on the Oslo stock exchange in 2010.

This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

Form 8.5 (EPT/NON-RI) – TESCO PLC – AMENDMENT

LONDON–(BUSINESS WIRE)–

FORM 8.5 (EPT/NON-RI)

AMENDMENT TO SECTION 2 (a) & 3 (a)

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN

EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY (“RI”) STATUS (OR WHERE RI STATUS IS NOT APPLICABLE)

Rule 8.5 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a)   Name of exempt principal trader:   BARCLAYS CAPITAL SECURITIES LTD
(b) Name of offeror/offeree in relation to whose TESCO PLC
  relevant securities this form relates:  
(c) Name of the party to the offer with which exempt TESCO PLC
  principal trader is connected  
(d) Date position held/dealing undertaken: 16 February 2017
(e) In addition to the company in 1(b) above, is the exempt principal YES:
  trader making disclosures in respect of any other party to the offer? BOOKER GROUP PLC

2. POSITIONS OF THE EXEMPT PRINCIPAL TRADER

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:   ORD
  Interests   Short Positions
    Number   (%) Number   (%)
(1) Relevant securities owned
and/or controlled: 24,764,006 0.30% 31,082,277 0.38%
           
(2) Cash-settled derivatives:
13,412,911 0.16% 6,529,411 0.08%
           
(3) Stock-settled derivatives (including options)
and agreements to purchase/sell: 0 0.00% 0 0.00%
           
(4)
TOTAL: 38,176,917 0.47% 37,611,688 0.46%

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:  
Details, including nature of the rights concerned and relevant percentages:  

3. DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant   Purchase/sale   Total number of   Highest price per unit   Lowest price per unit
security   securities paid/received paid/received
5p ORD Purchase 577,363 1.9725 GBP 1.9475 GBP
5p ORD Sale 908,110 1.9725 GBP 1.9475 GBP
ADR Purchase 9,428 7.3608 USD 7.28 USD
ADR Sale 9,428 7.3608 USD 7.28 USD

(b) Cash-settled derivative transactions

Class of   Product   Nature of dealing   Number of   Price per
relevant description reference unit
security     securities  
5p ORD CFD Long 3,525 1.9503 GBP
5p ORD CFD Long 9,812 1.9697 GBP
5p ORD CFD Long 12,635 1.9629 GBP
5p ORD SWAP Long 25,378 1.9576 GBP
5p ORD SWAP Long 27,405 1.9699 GBP
5p ORD SWAP Long 50,021 1.9647 GBP
5p ORD SWAP Long 99,541 1.9678 GBP
5p ORD SWAP Expires 20/03/2018 Long 118,021 1.9619 GBP
5p ORD SWAP Long 178,860 1.9661 GBP
5p ORD SWAP Short 1,900 1.9515 GBP
5p ORD SWAP Short 10,346 1.9656 GBP
5p ORD CFD Short 15,600 1.9522 GBP
5p ORD SWAP Short 27,412 1.9493 GBP
5p ORD CFD Short 61,367 1.9680 GBP
5p ORD SWAP Short 61,367 1.9680 GBP
5p ORD CFD Short 85,766 1.9595 GBP

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security   Product description e.g. call option   Writing, purchasing, selling, varying etc.   Number of securities to which option relates   Exercise price per unit   Type

e.g. American, European etc.

  Expiry date   Option money paid/ received per unit

(ii) Exercise

Class of relevant security   Product description

e.g. call option

  Exercising/ exercised against   Number of securities   Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security   Nature of dealing

e.g. subscription, conversion

  Details   Price per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?   YES
Date of disclosure: 20 Feb 2017
Contact name: Hemika Mistry
Telephone number: 020 7116 3891

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

143221.01

SUPPLEMENTAL FORM 8 (OPEN POSITIONS)

DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING OPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL ETC.

Note 5(i) on Rule 8 of the Takeover Code (the “Code”)

1. KEY INFORMATION

Identity of the person whose positions/dealings   BARCLAYS CAPITAL SECURITIES LTD
are being disclosed:  
Name of offeror/offeree in relation to whose TESCO PLC
relevant securities this from relates:  

2. STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)

Class   Product   Writing,   Number   Exercise   Type   Expiry
of description purchasing, of price date
relevant selling, securities per unit
security varying etc to which
option
      relates      
ORD Call Options Purchased 1,943,618 2.4248 European 7 Apr 2017

3. AGREEMENTS TO PURCHASE OR SELL ETC.

Full details should be given so that the nature of the interest or position can be fully understood:

It is not necessary to provide details on a Supplemental Form (Open Positions) with regard to cash-settled derivatives.

The currency of all prices and other monetary amounts should be stated.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170220005583/en/

BARCLAYS PLC

Source: BARCLAYS PLC


London Stock Exchange plc is not responsible for and does not check content on this Website. Website users are responsible for checking content. Any news item (including any prospectus) which is addressed solely to the persons and countries specified therein should not be relied upon other than by such persons and/or outside the specified countries. Terms and conditions, including restrictions on use and distribution apply.


Form 8.5 (EPT/NON-RI) – TESCO PLC – AMENDMENT – RNS

Growing Demand for Allergy Treatment Market 2024

Albany, NY — (SBWIRE) — 02/20/2017 — Global Allergy Treatment Market: Overview

Over the last few decades, there has been a dramatic rise in the prevalence of allergic diseases. According to the World Allergy Organization, an estimated 30% to 40% of the global population suffered from some form of allergic condition in 2011. The World Health Organization also stated that currently approximately 235 million people across the globe have asthma and another 100 million have rhinitis. Respiratory allergies have become the most common chronic disease among young adults and adolescents. This development has provided momentum to the global allergy treatment market.

Major types of allergies caused by food, drugs, insects, or the surrounding environment include rhinitis, conjunctivitis, eczema, and asthma. These allergies can be treated through either immunotherapy or anti-allergy medications such as corticosteroids, antihistamines, mast cell stabilizers, and decongestants. Clinics, hospitals, homes, and medical stores are the most preferred settings for the treatment of allergy.

The report offers in-depth information pertaining to the global allergy treatment market. The key drivers and challenges, the leading segments and sub-segments, and the threats and opportunities in the market have been determined and examined in detail. An exhaustive overview of the industrial structure, value chain, scope, and dynamics has been included in the study, along with a dedicated section on the vendor landscape. Prominent players competing at a global and regional level have been identified and a review of each company has been provided for a clearer understanding of the degree of competition.

Download Exclusive Brochure of This Report :

http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=11357

Global Allergy Treatment Market: Key Trends and Opportunities

A number of small and major factors is fueling the global allergy treatment market. Rise in the global population suffering from different types of allergies is a major factor driving the market. Changes in lifestyle and dietary habits, increase in environmental pollution, growing demand for advanced therapies targeted at allergy treatment, rising government initiatives, and a surge in research and development activities have also propelled the allergy treatment market.

Increase in alliances among leading players is another key factor that has augmented the global allergy treatment market. Allergy Therapeutics, a UK-based pharmaceutical company, acquired Spain-based Alerpharma S.A. in 2015 to expand its allergy immunotherapy product offerings. Later that year, Pfizer Inc. merged with Allergan plc to expand its share in the global drug industry.

On the other hand, side effects of immunotherapy and high cost of this treatment option act as major restraints of the global allergy treatment market.

Browse Global Strategic Business Report:http://www.transparencymarketresearch.com/allergy-treatment-market.html

Global Allergy Treatment Market: Region wise Outlook

North America and Europe dominated the global allergy treatment market in the past few years due to escalating percentage of population suffering from allergies of the skin, eyes, and respiratory system. In addition, presence of developed health care, rise in environmental pollution, and increase in demand for immunotherapy in the treatment of allergies have accelerated the growth of the allergy treatment markets in these two regions. Asia Pacific is likely to emerge as one of the strongest contenders in the allergy treatment market in the next few years due to the rising allergic patient population pool. Moreover, rapid development of health care infrastructure, growing awareness about the availability of advanced immunotherapy for the treatment various types of allergies, and the surge in government expenditure in the health care sector are anticipated to contribute to the growth of the Asia Pacific allergy treatment market.

The most promising players in the global allergy treatment market include Allergy Therapeutics, Meda Pharmaceuticals, Inc., Allergan plc, Schering-Plough Corporation, Alerpharma S.A., McNeil Consumer Healthcare, Allergopharma, Genentech, Inc., Allergon AB, Collegium Pharmaceutical, Inc., and Sepracor, Inc. These companies have been looking to enter into mergers and acquisitions in the allergy treatment market in order to expand their businesses.

Form 8.5 (EPT/NON-RI) – BOOKER GROUP PLC – Amendment

LONDON–(BUSINESS WIRE)–

FORM 8.5 (EPT/NON-RI)

AMENDMENT TO SECTION 2(a) AND 3(a)

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN

EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY (“RI”) STATUS (OR WHERE RI STATUS IS NOT APPLICABLE)

Rule 8.5 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a)   Name of exempt principal trader:   BARCLAYS CAPITAL SECURITIES LTD
(b) Name of offeror/offeree in relation to whose BOOKER GROUP PLC
  relevant securities this form relates:  
(c) Name of the party to the offer with which exempt TESCO PLC
  principal trader is connected  
(d) Date position held/dealing undertaken: 16 February 2017
(e) In addition to the company in 1(b) above, is the exempt principal YES:
  trader making disclosures in respect of any other party to the offer? TESCO PLC

2. POSITIONS OF THE EXEMPT PRINCIPAL TRADER

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:   ORD
  Interests   Short Positions
    Number   (%) Number   (%)
(1) Relevant securities owned
and/or controlled: 13,161,028 0.74% 9,254,228 0.52%
           
(2) Cash-settled derivatives:
1,193,379 0.07% 11,340,171 0.64%
           
(3) Stock-settled derivatives (including options)
and agreements to purchase/sell: 0 0.00% 0 0.00%
           
(4)
TOTAL: 14,354,407 0.80% 20,594,399 1.16%

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:  
Details, including nature of the rights concerned and relevant percentages:  

3. DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant   Purchase/sale   Total number of   Highest price per unit   Lowest price per unit
security   securities paid/received paid/received
ORD Purchase 300,949 2.0700 GBP 2.058 GBP
ORD Sale 371,490 2.0690 GBP 2.0592 GBP

(b) Cash-settled derivative transactions

Class of   Product   Nature of dealing   Number of   Price per
relevant description reference unit
security     securities  
ORD SWAP Long 100 2.0559 GBP
ORD SWAP Long 199 2.0669 GBP
ORD SWAP Long 974 2.0593 GBP
ORD SWAP Long 1,864 2.0634 GBP
ORD SWAP Long 3,571 2.0598 GBP
ORD SWAP Long 33,018 2.0607 GBP
ORD CFD Long 104,855 2.0614 GBP
ORD CFD Long 116,918 2.0610 GBP
ORD SWAP Short 699 2.0670 GBP
ORD SWAP Short 1,454 2.0610 GBP
ORD SWAP Short 3,200 2.0660 GBP
ORD CFD Short 4,905 2.0632 GBP
ORD CFD Short 78,964 2.0642 GBP

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security   Product description e.g. call option   Writing, purchasing, selling, varying etc.   Number of securities to which option relates   Exercise price per unit   Type

e.g. American, European etc.

  Expiry date   Option money paid/ received per unit

(ii) Exercise

Class of relevant security   Product description

e.g. call option

  Exercising/ exercised against   Number of securities   Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security   Nature of dealing

e.g. subscription, conversion

  Details   Price per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?   NO
Date of disclosure: 20 Feb 2017
Contact name: Hemika Mistry
Telephone number: 020 7116 3891

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170220005552/en/

BARCLAYS PLC

Source: BARCLAYS PLC


London Stock Exchange plc is not responsible for and does not check content on this Website. Website users are responsible for checking content. Any news item (including any prospectus) which is addressed solely to the persons and countries specified therein should not be relied upon other than by such persons and/or outside the specified countries. Terms and conditions, including restrictions on use and distribution apply.


Form 8.5 (EPT/NON-RI) – BOOKER GROUP PLC – Amendment – RNS

Form 8.5 (EPT/NON-RI) – LONDON STOCK EXCHANGE GROUP PLC – AMENDMENT

LONDON–(BUSINESS WIRE)–

FORM 8.5 (EPT/NON-RI) – AMENDMENT TO SECTION 2(a) & 3 (a)

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN

EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY (“RI”) STATUS (OR WHERE RI STATUS IS NOT APPLICABLE)

Rule 8.5 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a)   Name of exempt principal trader:   BARCLAYS CAPITAL SECURITIES LTD
(b) Name of offeror/offeree in relation to whose LONDON STOCK EXCHANGE GROUP PLC
  relevant securities this form relates:  
(c) Name of the party to the offer with which exempt LONDON STOCK EXCHANGE GROUP PLC
  principal trader is connected  
(d) Date position held/dealing undertaken: 15 February 2017
(e) In addition to the company in 1(b) above, is the exempt principal YES:
  trader making disclosures in respect of any other party to the offer? DEUTSCHE BOERSE AG

2. POSITIONS OF THE EXEMPT PRINCIPAL TRADER

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:       ORD            
Interests   Short Positions  
    Number (%) Number (%)
(1) Relevant securities owned
and/or controlled: 1,469,560 0.42% 842,012 0.24%
           
(2) Cash-settled derivatives:
83,977 0.02% 783,624 0.22%
           
(3) Stock-settled derivatives (including options)
and agreements to purchase/sell: 0 0.00% 0 0.00%
           
(4)
TOTAL: 1,553,537 0.44% 1,625,636 0.46%

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:  
Details, including nature of the rights concerned and relevant percentages:  

3. DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant   Purchase/sale   Total number of   Highest price per unit   Lowest price per unit
security   securities paid/received paid/received
ORD Purchase 32,943 31.3716 GBP 31.15 GBP
ORD Sale 36,444 31.4200 GBP 31.15 GBP

(b) Cash-settled derivative transactions

Class of   Product   Nature of dealing   Number of   Price per
relevant description reference unit
security     securities  
ORD SWAP Long 63 31.4296 GBP
ORD SWAP Long 947 31.3821 GBP
ORD SWAP Long 967 31.3758 GBP
ORD CFD Long 1,343 31.3911 GBP
ORD CFD Long 1,602 31.2177 GBP
ORD SWAP Long 2,121 31.1968 GBP
ORD SWAP Long 3,800 31.1734 GBP
ORD SWAP Long 4,433 31.2350 GBP
ORD CFD Long 7,719 31.2200 GBP
ORD CFD Short 44 31.1802 GBP
ORD CFD Short 119 31.1801 GBP
ORD SWAP Short 944 31.2642 GBP
ORD SWAP Short 969 31.2317 GBP
ORD CFD Short 1,126 31.1551 GBP
ORD CFD Short 1,426 31.1742 GBP
ORD SWAP Short 2,271 31.1709 GBP
ORD CFD Short 2,873 31.2395 GBP
ORD SWAP Short 3,342 31.2216 GBP
ORD SWAP Short 6,230 31.1700 GBP

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security   Product description e.g. call option   Writing, purchasing, selling, varying etc.   Number of securities to which option relates   Exercise price per unit   Type

e.g. American, European etc.

  Expiry date   Option money paid/ received per unit

(ii) Exercise

Class of relevant security   Product description

e.g. call option

  Exercising/ exercised against   Number of securities   Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security   Nature of dealing

e.g. subscription, conversion

  Details   Price per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?   NO
Date of disclosure: 20 Feb 2017
Contact name: Hemika Mistry
Telephone number: 020 7116 3891

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170220005559/en/

BARCLAYS PLC

Source: BARCLAYS PLC


London Stock Exchange plc is not responsible for and does not check content on this Website. Website users are responsible for checking content. Any news item (including any prospectus) which is addressed solely to the persons and countries specified therein should not be relied upon other than by such persons and/or outside the specified countries. Terms and conditions, including restrictions on use and distribution apply.


Form 8.5 (EPT/NON-RI) – LONDON STOCK EXCHANGE GROUP PLC – AMENDMENT – RNS

King & Spalding Continues Major Expansion of Corporate Practice in Houston With Team of Six Partners

HOUSTON, TX–(Marketwired – February 20, 2017) – King & Spalding has bolstered its energy practice today with a team of six transactional partners in Houston: David Runnels, Darren Inoff, Jason Peters, Cindy Lin, Stuart Zisman and Roxanne Almaraz.

“The addition of a team of corporate energy partners is a significant development for our global energy practice,” said Robert D. Hays, Jr., chairman of King & Spalding. “The team’s experience in M&A, projects, energy and other transactional matters enables King & Spalding to better serve our energy clients.”

King & Spalding has been in Houston for over 20 years and has more than 80 lawyers in Houston and more than 100 in Texas. The Houston office is one of the largest among firms headquartered outside Texas.

“The addition of this uniquely talented team to our Houston office is an exciting development,” said Tracie Renfroe, managing partner of the Houston office. “These six partners have prominent practices and are highly regarded transactional lawyers with deep Texas connections in the energy, projects and real estate sectors which will broaden our footprint in the region.”

“King & Spalding is the entire package — a global footprint, strong Texas roots and a well-deserved reputation for excellence,” said Runnels. “The firm’s commitment to growing its energy and corporate presence in Houston presents an exciting opportunity for all of us.”

“Joining as a group is a rare chance for all of us to grow our practices collectively,” said Zisman. “King & Spalding’s commitment to the Houston market, deep corporate bench, and highly ranked energy practice and energy regulatory stronghold complement our practices and provide day-one opportunities to dramatically grow our collective offering. We look forward to working with our new colleagues across the firm.”

David Runnels, Darren Inoff, Jason Peters and Cindy Lin, were previously partners at Andrews Kurth, while Stuart Zisman and Roxanne Almaraz, were formerly partners at Bracewell.

David Runnels

Runnels’s practice extends across many diverse industries, with particular emphasis on renewable energy, conventional energy and real estate. He has spent over 30 years advising clients on matters including mergers, acquisitions and dispositions, project development and complex asset-based financings. Runnels is a former member of the management committee of Andrews Kurth. He received his undergraduate degree in finance with high honors and J.D. with honors from the University of Texas at Austin.

Darren Inoff

Inoff’s practice includes a broad spectrum of corporate and real estate matters. His focus is on joint ventures, mergers and acquisitions and other strategic corporate transactions in primarily the healthcare, energy, real estate and food and beverage industries. In addition, he has substantial experience working on a wide range of complex real estate matters. His clients include private equity sponsors, real estate funds and REIT’s. Inoff is also a former member of the management committee of Andrews Kurth and served as chair of its Business Transactions section. He received his undergraduate degree with highest honors and Phi Beta Kappa and J.D. with honors from The University of Texas at Austin.

Jason Peters

Peters focuses on the acquisition and sale of private companies and the representation of private equity sponsors and companies in a variety of domestic and cross-border finance transactions, including asset based financings, dividend recapitalizations and leveraged acquisitions. He has represented private equity firms and companies in numerous industries, including energy, metals, pulp and paper, packaging, wood products, construction and restaurants. Peters received his undergraduate degree from Vanderbilt University and his J.D. from University of Houston.

Cindy Lin

Lin represents clients in all facets of corporate law, with a particular focus on mergers and acquisitions, private equity and venture capital. She has extensive experience in acquiring and selling stock and assets of companies in domestic and cross-border transactions for public and private clients, private placement offerings for issuers, and assisting emerging companies and investors in initial and subsequent rounds of financing. Lin’s practice spans across a wide range of industries, with an emphasis on the energy industry. Most recently, Lin has assisted clients in the purchase and sale of several power plants, power development projects and oilfield service companies. Lin earned both her undergraduate degree, with honors, and J.D. from The University of Texas at Austin.

Stuart Zisman

Zisman focuses on energy projects and related transactions in the midstream and downstream energy sectors (including power). He has experience with energy projects of all types and in all stages of ownership and operation, from the early development stage through their operating life cycles (e.g., operation and optimization). Zisman also has considerable experience with energy commodity transactions and acquisitions, divestitures and joint ventures involving energy companies and assets. He earned his undergraduate degrees in accounting and finance, with honors, from The University of Texas at Austin and his J.D. from New York University School of Law.

Roxanne Almaraz

Almaraz is a highly experienced energy transactional lawyer who works on complex domestic and international mergers and acquisitions, joint ventures and other business transactions involving energy assets. Her experience spans the energy industry, having represented strategic and financial investors, multinational companies and private equity firms in the conventional power/utilities, renewables, and midstream and upstream oil and gas sectors. She earned her undergraduate degrees, each with highest honors, from The University of Texas at Austin, and her J.D. from Stanford Law School.

About King & Spalding

Celebrating more than 130 years of service, King & Spalding is an international law firm that represents a broad array of clients, including half of the Fortune Global 100, with 1,000 lawyers in 19 offices in the United States, Europe, the Middle East and Asia. The firm has handled matters in over 160 countries on six continents and is consistently recognized for the results it obtains, uncompromising commitment to quality, and dedication to understanding the business and culture of its clients. More information is available at www.kslaw.com.

Mobylife publishes 2016 Annual Report

Mobylife’s 2016 Annual Report is now available at mobylife.com at the corporate section.The statutory statement on Corporate governance, according to ÅRL § 107 b, is an integrated part of the 2016 annual report.
Mobylife will host an investor conference call at Wednesday 22 February 11.00 (CET).
Dial in: +45 8111 1213
Access code: 35254552
Jakob H. Kraglund
CEO
For further information on this announcement:Martin Nyberg, CFO, tel. +45 29298200, martin.nyberg@mobylife.dkAttachments:http://www.globenewswire.com/NewsRoom/AttachmentNg/358430f0-cfb4-4554-981e-36a199fd8365